Dhiman A, Rana D, Benival D, Garkhal K
Ther Deliv. 2024; 16(1):87-115.
PMID: 39445563
PMC: 11703381.
DOI: 10.1080/20415990.2024.2415281.
Scheer M, Polak M, Fritzsche S, Strauss C, Scheller C, Leisz S
Int J Mol Sci. 2024; 25(19).
PMID: 39408743
PMC: 11476576.
DOI: 10.3390/ijms251910389.
Mishchenko T, Turubanova V, Gorshkova E, Krysko O, Vedunova M, Krysko D
Front Immunol. 2024; 14:1299064.
PMID: 38274827
PMC: 10809268.
DOI: 10.3389/fimmu.2023.1299064.
Segura P, Vilarino Quintela N, Martinez Garcia M, Del Barco Berron S, Girones Sarrio R, Gomez J
Clin Transl Oncol. 2023; 25(9):2634-2646.
PMID: 37540408
PMC: 10425506.
DOI: 10.1007/s12094-023-03245-y.
Pepper N, Stummer W, Eich H
Strahlenther Onkol. 2022; 198(6):507-526.
PMID: 35503461
PMC: 9165247.
DOI: 10.1007/s00066-022-01942-1.
Cell-based immunotherapy of glioblastoma multiforme.
Bryukhovetskiy I
Oncol Lett. 2022; 23(4):133.
PMID: 35251352
PMC: 8895466.
DOI: 10.3892/ol.2022.13253.
Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma.
Ahn S, Kim Y, Shin J, Park J, Yoo C, Lee Y
Oncol Lett. 2022; 23(4):114.
PMID: 35251345
PMC: 8850950.
DOI: 10.3892/ol.2022.13234.
A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
Butt O, Zhou A, Huang J, Leidig W, Silberstein A, Chheda M
Neurooncol Adv. 2022; 3(1):vdab164.
PMID: 34988450
PMC: 8694207.
DOI: 10.1093/noajnl/vdab164.
Hematological Changes Following Low Dose Radiation Therapy and Comparison to Current Standard of Care Cancer Treatments.
Jameus A, Kennedy A, Thome C
Dose Response. 2021; 19(4):15593258211056196.
PMID: 34803549
PMC: 8600563.
DOI: 10.1177/15593258211056196.
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.
McBain C, Lawrie T, Rogozinska E, Kernohan A, Robinson T, Jefferies S
Cochrane Database Syst Rev. 2021; 5:CD013579.
PMID: 34559423
PMC: 8121043.
DOI: 10.1002/14651858.CD013579.pub2.
Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome.
Ferranti S, Sardi I, Guidi M, Lembo C, Grosso S
Front Pediatr. 2021; 9:648717.
PMID: 33763397
PMC: 7982648.
DOI: 10.3389/fped.2021.648717.
Reirradiation of High-Grade Gliomas: A Retrospective Analysis of 198 Patients Based on the Charité Data Set.
Kaul D, Pudlitz V, Bohmer D, Wust P, Budach V, Grun A
Adv Radiat Oncol. 2020; 5(5):959-964.
PMID: 33083659
PMC: 7557122.
DOI: 10.1016/j.adro.2020.06.005.
Innovative therapies for malignant brain tumors: the road to a tailored cure.
Lucifero A, Luzzi S, Brambilla I, Trabatti C, Mosconi M, Savasta S
Acta Biomed. 2020; 91(7-S):5-17.
PMID: 32608372
PMC: 7975829.
DOI: 10.23750/abm.v91i7-S.9951.
PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma.
Sharpe M, Raghavan S, Baskin D
Oncotarget. 2018; 9(35):23923-23943.
PMID: 29844863
PMC: 5963626.
DOI: 10.18632/oncotarget.25246.
High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.
Yu K, Taylor J, Pathmanaban O, Youshani A, Beyit D, Dutko-Gwozdz J
PLoS One. 2018; 13(3):e0193694.
PMID: 29499065
PMC: 5834163.
DOI: 10.1371/journal.pone.0193694.
Management and treatment recommendations for World Health Organization Grade III and IV gliomas.
Altwairgi A, Raja S, Manzoor M, Aldandan S, Alsaeed E, Balbaid A
Int J Health Sci (Qassim). 2017; 11(3):54-62.
PMID: 28936153
PMC: 5604271.
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S, Talari G, Rosenfeld M, Guo J, Villano J
Cochrane Database Syst Rev. 2017; 7:CD011773.
PMID: 28744879
PMC: 6483418.
DOI: 10.1002/14651858.CD011773.pub2.
Malignant gliomas: old and new systemic treatment approaches.
Mesti T, Ocvirk J
Radiol Oncol. 2016; 50(2):129-38.
PMID: 27247544
PMC: 4852970.
DOI: 10.1515/raon-2015-0003.
Strategies to target drugs to gliomas and CNS metastases of solid tumors.
Milojkovic Kerklaan B, van Tellingen O, Huitema A, Beijnen J, Boogerd W, Schellens J
J Neurol. 2015; 263(3):428-40.
PMID: 26477024
DOI: 10.1007/s00415-015-7919-9.
CNS Anticancer Drug Discovery and Development Conference White Paper.
Levin V, Tonge P, Gallo J, Birtwistle M, Dar A, Iavarone A
Neuro Oncol. 2015; 17 Suppl 6:vi1-26.
PMID: 26403167
PMC: 4581696.
DOI: 10.1093/neuonc/nov169.
